These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8706288

  • 21. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ, Watt HC, Hackshaw AK.
    N Engl J Med; 1999 Aug 12; 341(7):461-7. PubMed ID: 10441601
    [Abstract] [Full Text] [Related]

  • 22. Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies.
    Wenstrom KD, Owen J, Chu DC, Boots L.
    Am J Obstet Gynecol; 1997 Nov 12; 177(5):992-6. PubMed ID: 9396881
    [Abstract] [Full Text] [Related]

  • 23. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome.
    Spencer K, Wood PJ, Anthony FW.
    Ann Clin Biochem; 1993 Mar 12; 30 ( Pt 2)():219-20. PubMed ID: 8466163
    [No Abstract] [Full Text] [Related]

  • 24. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M, Nørgaard-Pedersen B.
    Clin Genet; 2005 Jul 12; 68(1):35-9. PubMed ID: 15952984
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
    Cuckle HS, Holding S, Jones R.
    Prenat Diagn; 1994 May 12; 14(5):387-90. PubMed ID: 7521963
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies.
    Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP.
    Prenat Diagn; 1995 Apr 12; 15(4):385-6. PubMed ID: 7617583
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Measuring maternal serum screening markers for Down's syndrome in plasma collected for cell-free DNA testing.
    Lambert-Messerlian GM, Eklund EE, Neveux LM, Palomaki GE.
    J Med Screen; 2017 Sep 12; 24(3):113-119. PubMed ID: 28756761
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D, Bradbury I, Malone F, D'Alton M, Summers A, Huang T, Ball S, Baker A, Nix B, Aitken D, Crossley J, Cuckle H, Spencer K.
    Health Technol Assess; 2010 Jul 12; 14(33):1-80. PubMed ID: 20624355
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.